UnitedHealth Group Incorporated $UNH Shares Sold by Security National Bank

Key Points

• Security National Bank reduced its stake in UnitedHealth Group by 64.0%, owning only 6,213 shares, valued at approximately $1.94 million, after selling over 11,000 shares in the second quarter.
• UnitedHealth Group's quarterly earnings fell short of expectations, reporting an earnings per share of $4.08, missing estimates by $0.37, with revenue of $111.62 billion.
• The company announced a quarterly dividend of $2.21, with a current yield of 2.6%, and will be paid to investors of record on September 15th.

Security National Bank trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 64.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,213 shares of the healthcare conglomerate's stock after selling 11,065 shares during the quarter. Security National Bank's holdings in UnitedHealth Group were worth $1,938,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the period. Two Sigma Advisers LP purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $14,063,000. First Heartland Consultants Inc. increased its position in shares of UnitedHealth Group by 6.3% during the fourth quarter. First Heartland Consultants Inc. now owns 1,240 shares of the healthcare conglomerate's stock worth $627,000 after acquiring an additional 74 shares during the period. Finally, Novem Group purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $854,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the stock. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sanford C. Bernstein lifted their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a report on Friday, September 5th. Truist Financial lifted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a report on Tuesday, September 9th. Oppenheimer cut their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Finally, Royal Bank Of Canada cut their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $358.95.

UnitedHealth Group Stock Up 0.6%

NYSE UNH traded up $1.90 on Friday, hitting $336.72. The stock had a trading volume of 13,528,738 shares, compared to its average volume of 13,748,202. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The business's fifty day moving average price is $295.67 and its 200 day moving average price is $365.19. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market cap of $304.96 billion, a price-to-earnings ratio of 14.59, a price-to-earnings-growth ratio of 2.19 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the firm posted $6.80 earnings per share. The company's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.